NIH DIRECTOR SELECTS DR. ROGER I. GLASS AS FOGARTY INTERNATIONAL CENTER DIRECTOR

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



U.S. Department of Health and Human Services 
NATIONAL INSTITUTES OF HEALTH 
NIH News 
NIH Office of the Director (OD)  
http://www.nih.gov/icd/od/

FOR IMMEDIATE RELEASE: Friday, March 31, 2006  

CONTACT: NIH Office of Communications and Public Liaison, 301-496-5787,
http://www.nih.gov/icd/od/  

NIH DIRECTOR SELECTS DR. ROGER I. GLASS AS FOGARTY INTERNATIONAL CENTER
DIRECTOR

Bethesda, Maryland -- Elias A. Zerhouni, M.D., director of the National
Institutes of Health (NIH), today announced that Roger I. Glass, M.D.,
Ph.D., will be the new director of the Fogarty International Center
(FIC) and Associate Director of NIH for international programs. Dr.
Glass, who is currently the chief of the Viral Gastroenteritis Section
at the Centers for Disease Control and Prevention in Atlanta, Georgia,
will join NIH in May, 2006.

"Dr. Glass is a leading scientist and recognized expert in the
development and introduction of rotavirus vaccines in the developing
world," Dr. Zerhouni said. "His global view of the disease burden caused
by infections and diseases will ensure that the Fogarty International
Center continues to move forward in the quest to eliminate health
disparities worldwide."

"I am honored to lead the Fogarty International Center," said Dr. Glass.
"The Center has a long history of funding programs to target infectious
diseases that are highly prevalent in developing nations, such as AIDS,
tuberculosis, and malaria. But it is in initiating programs that reflect
the newest opportunities and challenges in predicting emerging global
health problems that the Fogarty Center has been particularly
noteworthy."

Dr. Glass will oversee an annual budget of more than $60 million. The
Fogarty International Center promotes and supports scientific research
and training internationally to reduce disparities in global health. FIC
has assumed a leadership role in formulating and implementing biomedical
research and policy.

Dr. Glass graduated from Harvard College in 1967, received a Fulbright
Fellowship to study at the University of Buenos Aires in 1967, and
received his M.D. from Harvard Medical School and his M.P.H. from the
Harvard School of Public Health in 1972. Dr. Glass joined the CDC in
1977 as a medical officer assigned to the Environmental Hazards Branch.
He received his doctorate from the University of Goteborg, Sweden in
1983, and joined the National Institutes of Health Laboratory of
Infectious Diseases, where he worked on the molecular biology of
rotavirus. In 1986, Dr. Glass returned to the CDC to become Chief of the
Viral Gastroenteritis Unit at the National Center for Infectious
Diseases.

Dr. Glass's research interests are in the prevention of gastroenteritis
from rotaviruses and nonviruses through the application of novel
scientific research. He has maintained field studies in India,
Bangladesh, Brazil, Mexico, Israel, Russia, Vietnam, China and
elsewhere. His research has been targeted toward epidemiologic studies
to anticipate the introduction of rotavirus vaccines. He is fluent and
often lectures in 5 languages.

Dr. Glass has received numerous awards, including the Secretary's Award
for Distinguished Service (DHHS), the Outstanding Unit Citation from the
National Center for Infectious Diseases, the Outstanding Service Medal
from the U.S. Public Health Service, and a Commendation Medal from the
U.S. Public Health Service. He is a member of the U.S. National Academy
of Science's Institute of Medicine, the American Academy of
Microbiology, the American Society of Microbiology, the American
Association for the Advancement of Science, the American Society of
Virology, and the American Epidemiological Society. Dr. Glass is also a
fellow in the Infectious Disease Society and the American College of
Epidemiology.

Dr. Glass has co-authored more than 400 research papers and chapters. He
is married to Barbara Stoll, M.D., the George W. Brumley, Jr. Professor
and Chair of the Department of Pediatrics at Emory University School of
Medicine and the Medical Director of the Children's Healthcare of
Atlanta at Egleston. He and his wife have three children.

FIC, the international component of the NIH, addresses global health
challenges through innovative and collaborative research and training
programs and supports and advances the NIH mission through international
partnerships. 
 
The Office of the Director, the central office at NIH, is responsible
for setting policy for NIH, which includes 27 Institutes and Centers.
This involves planning, managing, and coordinating the programs and
activities of all NIH components. The Office of the Director also
includes program offices which are responsible for stimulating specific
areas of research throughout NIH. Additional information is available at
http://www.nih.gov/icd/od/. 

The National Institutes of Health (NIH) -- "The Nation's Medical
Research Agency" -- includes 27 Institutes and Centers and is a
component of the U.S. Department of Health and Human Services. It is the
primary federal agency for conducting and supporting basic, clinical and
translational medical research, and it investigates the causes,
treatments, and cures for both common and rare diseases. For more
information about NIH and its programs, visit http://www.nih.gov.
  
##
 
This NIH News Release is available online at:
http://www.nih.gov/news/pr/mar2006/od-31.htm.

To subscribe (or unsubscribe) from this list, go to
http://list.nih.gov/cgi-bin/wa?SUBED1=nihpress&A=1.

[Index of Archives]     [CDC News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux